Turning The Spotlight On Limelight Networks

Jul. 03, 2015 6:34 PM ETEdgio, Inc. (EGIO) Stock5 Comments

Summary

  • Almost two years ago I profiled a small CDN play named Limelight Networks that was in the midst of a turnaround plan that I believed had merit.
  • The stock was selling at under $2.00 a share at the time but I liked the risk/reward profile of the stock for many reasons.
  • Since then the stock has more than doubled to over $4.00 a share. However, there may be more upside ahead as the company continues to improve its business.
  • Given the amount of M&A activity going on in the markets, this small-cap concern could easily be gobbled up by a larger competitor as well.

It has been almost two years since I first shined the spotlight on a small content delivery network (or CDN) named Limelight Networks (LLNW). The stock was selling at a little less than $2.00 a share at the time after falling on some hard times. At the time of my profile, the company was just initiating a turnaround strategy and had brought in a new CEO to deliver improved shareholder returns. I thought the strategy had a good chance to succeed and liked the risk/reward profile of Limelight from an investment perspective.

It turned out to be a correct call as new leadership has improved the company's underlying business fundamentals. The stock has more than doubled since that article ran to over $4.00 a share. As a nice of return as that has been, I still have a small stake in this small-cap play. The story still has many positives to it and further upside could well be ahead. Here are some of things I still like about Limelight Networks.

Insider Buying and Cash Balance:

One of the things that gives me confidence holding my stake even though the stock is up more than 100% over the past couple of years is insiders have confidence in Limelight Networks' future. You can see this being demonstrated by the myriad directors who have continue to make frequent purchases of the shares in 2015 even as the stock has rallied substantially. In addition, the company has a pristine balance sheet with some $80 million in net cash on the books which is almost 20% of the company's overall market capitalization of ~$425 million.

The Trend Is Your Friend:

Since I penned that article in August of 2013, the company has done a good job improving its operational efficiencies. Expenses have gone from roughly 60% of revenue

This article was written by

Bret Jensen profile picture
48.87K Followers

Bret Jensen has over 13 years as a market analyst, helping investors find big winners in the biotech sector. Bret specializes in high beta sectors with potentially large investor returns.

Bret leads the investing group The Biotech Forum, in which he and his team offer a model portfolio with their favorite 12-20 high upside biotech stocks, live chat to discuss trade ideas, and weekly research and option trades. The group also provides market commentary and a portfolio update every weekend. Learn More.

Analyst’s Disclosure: I am/we are long LLNW. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About EGIO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Prev. Close
Compare to Peers

More on EGIO

Related Stocks

SymbolLast Price% Chg
EGIO
--